| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 02/15/2007 | US20070037234 Fluorogenic enzyme substrates and methods of preparation |
| 02/15/2007 | DE10242062B4 Hydrierte kondensierte Palatinose, Verfahren zu deren Herstellung und deren Verwendung Hydrogenated condensed palatinose, processes for their preparation and their use |
| 02/14/2007 | EP1751171A1 Novel galactoside inhibitors of galectins |
| 02/14/2007 | EP1750726A2 Spermicidal and virucidal properties of various forms of sophorolipids |
| 02/14/2007 | EP1402886B1 Lipolysis accelerator for reducing body weight and medicinal use |
| 02/14/2007 | CN1914220A Prodrug comprising 5-aminosalicylate glycoside |
| 02/14/2007 | CN1911950A Preparation method of intermediate for synthesizing trichloro saccharose |
| 02/14/2007 | CN1911949A Method of chemical synthesizing hongjingtian glycoside |
| 02/14/2007 | CN1300161C Yellow pigment of safflower preparation method and application |
| 02/14/2007 | CN1300160C Fatty acid ester compounds of ginsenoside secondary glycoside compound K and method for preparing same |
| 02/14/2007 | CN1300159C Ibuprofen sugar derivative and its preparing process and use |
| 02/13/2007 | CA2275191C Phosphorescent dendritic macromolecular compounds for imaging tissue oxygen |
| 02/13/2007 | CA2084987C Nucleic acid ligands |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032407 Use treating hepatitis C infection optionally with other viricides such as interferons or ribavirin; low toxicity to the host; use of cytosine-based nucleotides or nucleosides having a 2'-trifluoromethyl-ribose moiety which forms a 5'-phosphate or hydroxy moiety in vivo |
| 02/08/2007 | US20070031523 purified plant extract for treating menopausal-syndrome; no side effect; ameliorating ovary function and regulating estrogen and progestogen, prevent many diseases due to imbalance of estrogen and progestrogen; for patients which need to use estrogen but with contraindication of hormone |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/08/2007 | CA2616294A1 Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors |
| 02/07/2007 | EP1506211B1 C-aryl glucoside sglt2 inhibitors and method |
| 02/06/2007 | US7173107 Glycopeptide and preparation thereof |
| 02/06/2007 | CA2287262C Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 02/01/2007 | WO2007013522A1 Simon potato extract, glycosphingolipid derived from simon potato, and process for production of the extract or glycosphingolipid |
| 02/01/2007 | WO2006091580A3 Hydrophobic starch compositions and uses of starch as fuel |
| 02/01/2007 | DE102004010219B4 HKI10311129, neues Antibiotikum, Verfahren zu dessen Herstellung und Arzneimittel enthaltend HKI10311129 HKI10311129, new antibiotic, to processes for its preparation and medicines containing HKI10311129 |
| 01/31/2007 | EP1747783A1 Oral flora-improving agent, antibacterial agent and growth promoter |
| 01/31/2007 | CN1906203A Glycosaminoglycan (GAG) mimetics |
| 01/31/2007 | CN1903868A Preparation method of etoposide phosphate |
| 01/31/2007 | CN1903867A New crystalline type 3,4',5-trihydroxy stilbene-3-beta-D-glucocide |
| 01/31/2007 | CN1297563C Clindamycin and metronidazole pessary |
| 01/30/2007 | US7169919 Genetically engineered lipids for use in the treatment baterial infection |
| 01/30/2007 | US7169753 Such as magnesium-containing tetrahydroporphyrin for use in photodynamic therapy, tumor diagnosis, bactericides, and viricides; transesterification |
| 01/25/2007 | WO2007009772A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 01/25/2007 | WO2006121861A3 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/25/2007 | WO2006054304A3 Use of lipid conjugates in the treatment of disease |
| 01/25/2007 | WO2005118777A8 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 01/25/2007 | CA2615860A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 01/25/2007 | CA2615434A1 Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 01/24/2007 | EP1745790A2 Treatment of rumen acidosis with alpha-amylase inhibitors |
| 01/24/2007 | EP1745060A2 Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production |
| 01/24/2007 | EP1370570B1 Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein c |
| 01/24/2007 | CN1296047C Caloporoside derivatives, methods for production thereof and their use |
| 01/23/2007 | CA2130794C Esterified alkoxylated polyol fat substitutes having high primary ester content |
| 01/18/2007 | WO2007006152A1 Compositions from buckwheat for management of diabetes |
| 01/18/2007 | WO2006124720B1 Multidrug resistant anticancer anthracyclines |
| 01/18/2007 | WO2005084307A3 Use of lipid conjugates in the treatment of disease |
| 01/18/2007 | US20070015717 E-4-[2-methyl-2-(1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphth-7-yl)-vinyl]-phenyl-2'-(4'methoxyphenyl)-1'-ethanone; cancer |
| 01/18/2007 | DE102005033903A1 New perfluoroalkyl-containing metal complexes, useful for production of contrast agents for use in e.g. NMR and X-ray diagnostics, necrosis imaging and in radiodiagnostics and radiotherapy |
| 01/17/2007 | EP1742988A1 Grafted polymer comprising a polyorganosiloxane backbone and gylcoside units |
| 01/17/2007 | CN1898202A Anti-hypercholesterolemic compounds |
| 01/17/2007 | CN1896088A C－芳基葡糖苷sglt2抑制剂 C- aryl glucoside sglt2 inhibitors |
| 01/17/2007 | CN1295238C Process for preparing powder containing maltose alcohol crystal grains |
| 01/16/2007 | US7164015 Lithiating aromatic reactant in microreactor, then coupling with carbonyl substituted reactant |
| 01/16/2007 | US7164011 including gram positive organisms |
| 01/16/2007 | US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/11/2007 | WO2007004705A1 Glycolipid derivative and therapeutic agent comprising the same as active ingredient |
| 01/11/2007 | WO2007003236A1 Process for synthesis of complex 2-deoxy-2-iodo pyranosides of high purity, particularly suitable for manufacturing pharmaceutically pure annamycin |
| 01/11/2007 | WO2006053972A3 Silanizing agents comprising a saccharide end group and uses thereof, such as for the functionalization of solid supports |
| 01/11/2007 | CA2613350A1 Glycolipid derivative and drug containing the same as active component |
| 01/10/2007 | EP1740599A1 Anthracycline derivatives |
| 01/10/2007 | CN1894306A Modified alkoxylated polyol compounds |
| 01/10/2007 | CN1894305A Modified alkoxylated polyol compounds |
| 01/10/2007 | CN1294140C Process for is olating and purifying secoisolarisiresinol diglycoside (SDG) from flaxseed |
| 01/09/2007 | US7160992 Amino-modified polysaccharides and methods of generating and using same |
| 01/09/2007 | US7160867 Rapamycin carbohydrate derivatives |
| 01/09/2007 | US7160856 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents |
| 01/04/2007 | WO2007000967A1 Remedy for cerebral infarction |
| 01/04/2007 | WO2004062599A3 Certain aminoalkyl glucosaminide phosphate compounds and their use |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004011 Phenylpropanoids from lilac flowers for drug,nutritional and cosmetic uses; stabilized cell lines with highantioxidant capacity; oxidative stress relieving; verbascoside/ isoverbascoside as wound healing agents; culture of plant cell line to a thermal enzyme deactivating treatment; industrial scale |
| 01/03/2007 | CN1293089C Low calorie candy made from luohanguo and its production |
| 01/03/2007 | CN1293088C Stabilization of amrubicin hydrochloride |
| 01/03/2007 | CN1293087C Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| 01/02/2007 | US7157432 Tetraphenylbacteriochlorin derivatives and compositions containing the same |
| 01/02/2007 | US7157078 bait matrix comprising: a termiticide that causes death to 50-100% of termites within 24-84 days after the termites begin to ingest it; a cellulose containing material; and water; can be used in a bait station installed in the ground; kits may be used by consumers in their homes. |
| 12/28/2006 | WO2006136933A2 Composition for the treatment and/or prevention of attacks by biological agents |
| 12/28/2006 | WO2006136429A1 Compounds for the treatment of non-autoimmune type 2 diabetes mellitus and/or syndrome x |
| 12/28/2006 | WO2006105222A3 Carboxamide inhibitors of tgfb |
| 12/28/2006 | WO2006003518A3 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 12/28/2006 | US20060293249 Porphyrin derivatives |
| 12/27/2006 | EP1736167A2 Extracts obtained from cell line cultures from plants belonging to the Oleaceae family (e.g. Syringa vulgaris), their preparation and use |
| 12/27/2006 | EP1736166A2 Extracts from Ajuga reptans cell lines, their preparation and use |
| 12/27/2006 | EP1735323A1 Synthetic membrane anchors |
| 12/27/2006 | EP0638123B1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 12/27/2006 | CN1884293A Anthraquinone glycoside compound with anti ovary tumour effect |
| 12/27/2006 | CN1291723C Extended type 1 chain glycosphingolipids as tumer-associated antigens |
| 12/26/2006 | US7153946 Molecular conjugates for use in treatment of cancer |
| 12/21/2006 | WO2006135084A1 Prophylactic or therapeutic agent for steatohepatitis or fatty liver |
| 12/21/2006 | WO2006135083A1 Prophylactic or therapeutic agent for visceral fat syndrome |
| 12/21/2006 | WO2006134352A1 Method for the synthesis of anthocyanins |
| 12/21/2006 | US20060287255 C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth |
| 12/20/2006 | EP1734046A1 Radiosensitizer |
| 12/20/2006 | EP1732931A1 METHODS FOR THE PREPARATION OF (3R,3aS,6aR) HEXAHYDRO-FURO[2,3-b]FURAN-3-OL |
| 12/20/2006 | EP1172107B1 Drugs containing sulfopyranosylacylglycerol derivatives |
| 12/20/2006 | CN1882605A Improved expression systems using Sec-system secretion |
| 12/20/2006 | CN1882601A Synthetic compounds useful as nodulation agents of leguminous plants and preparation processes thereof |
| 12/20/2006 | CN1880327A Method for preparing open loop secoisolariciresinol diglucoside from flax seed |
| 12/20/2006 | CN1880326A Two-step resin method for preparing salidrose |
| 12/20/2006 | CN1290854C Gentamicin, preparation method and uses thereof |
| 12/20/2006 | CN1290853C Purifying method for moenomycin |
| 12/20/2006 | CN1290852C Method for extracting beta-glucoside from waste mushroom culture medium |